Stock Analysis

Analyst Estimates: Here's What Brokers Think Of 3M India Limited (NSE:3MINDIA) After Its Full-Year Report

NSEI:3MINDIA
Source: Shutterstock

Shareholders of 3M India Limited (NSE:3MINDIA) will be pleased this week, given that the stock price is up 10% to ₹34,001 following its latest yearly results. The result was positive overall - although revenues of ₹43b were in line with what the analyst predicted, 3M India surprised by delivering a statutory profit of ₹518 per share, modestly greater than expected. The analyst typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. With this in mind, we've gathered the latest statutory forecasts to see what the analyst is expecting for next year.

Check out our latest analysis for 3M India

earnings-and-revenue-growth
NSEI:3MINDIA Earnings and Revenue Growth May 31st 2024

After the latest results, the single analyst covering 3M India are now predicting revenues of ₹47.9b in 2025. If met, this would reflect a meaningful 12% improvement in revenue compared to the last 12 months. Statutory earnings per share are predicted to ascend 13% to ₹583. In the lead-up to this report, the analyst had been modelling revenues of ₹48.2b and earnings per share (EPS) of ₹558 in 2025. The analyst seem to have become more bullish on the business, judging by their new earnings per share estimates.

The consensus price target was unchanged at ₹39,500, implying that the improved earnings outlook is not expected to have a long term impact on value creation for shareholders.

Looking at the bigger picture now, one of the ways we can make sense of these forecasts is to see how they measure up against both past performance and industry growth estimates. The analyst is definitely expecting 3M India's growth to accelerate, with the forecast 12% annualised growth to the end of 2025 ranking favourably alongside historical growth of 9.3% per annum over the past five years. Compare this with other companies in the same industry, which are forecast to grow their revenue 6.1% annually. It seems obvious that, while the growth outlook is brighter than the recent past, the analyst also expect 3M India to grow faster than the wider industry.

The Bottom Line

The biggest takeaway for us is the consensus earnings per share upgrade, which suggests a clear improvement in sentiment around 3M India's earnings potential next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was no real change to the consensus price target, suggesting that the intrinsic value of the business has not undergone any major changes with the latest estimates.

With that in mind, we wouldn't be too quick to come to a conclusion on 3M India. Long-term earnings power is much more important than next year's profits. At least one analyst has provided forecasts out to 2026, which can be seen for free on our platform here.

Even so, be aware that 3M India is showing 1 warning sign in our investment analysis , you should know about...

Valuation is complex, but we're helping make it simple.

Find out whether 3M India is potentially over or undervalued by checking out our comprehensive analysis, which includes fair value estimates, risks and warnings, dividends, insider transactions and financial health.

View the Free Analysis

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.